Free Trial
CVE:IFX

Imaflex (IFX) Stock Price, News & Analysis

Imaflex logo
C$1.30 0.00 (0.00%)
As of 07/4/2025 03:19 PM Eastern

About Imaflex Stock (CVE:IFX)

Key Stats

Today's Range
C$1.30
C$1.36
50-Day Range
C$1.05
C$1.38
52-Week Range
C$1.01
C$1.65
Volume
1,730 shs
Average Volume
12,450 shs
Market Capitalization
C$67.22 million
P/E Ratio
11.71
Dividend Yield
3.94%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imaflex and its competitors with MarketBeat's FREE daily newsletter.

IFX Stock News Headlines

The #1 AI Energy Stock
Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.
Returns Are Gaining Momentum At Imaflex (CVE:IFX)
See More Headlines

IFX Stock Analysis - Frequently Asked Questions

Imaflex's stock was trading at C$1.41 at the beginning of the year. Since then, IFX shares have decreased by 7.8% and is now trading at C$1.30.

Shares of IFX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imaflex investors own include Walt Disney (DIS), AstraZeneca (AZN), Beam Global (BEEM), Brookfield Renewable (BEPC), GSK (GSK), KeyCorp (KEY) and Li Auto (LI).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Packaging & Containers
Sub-Industry
N/A
Current Symbol
CVE:IFX
CIK
N/A
Fax
N/A
Employees
264
Year Founded
N/A

Profitability

Trailing P/E Ratio
11.71
Forward P/E Ratio
8.68
P/E Growth
N/A
Net Income
C$5.70 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$106.87 million
Cash Flow
C$0.12 per share
Price / Cash Flow
10.98
Book Value
C$1.21 per share
Price / Book
1.08

Miscellaneous

Free Float
N/A
Market Cap
C$67.22 million
Optionable
Not Optionable
Beta
0.35
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (CVE:IFX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners